Spy II Clinical Registry

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

October 31, 2009

Conditions
Biliary Tract Diseases
Interventions
DEVICE

SpyGlass

The SpyGlass Direct Visualization System is an integrated product platform that is designed to provide a direct intraluminal view of the biliary duct system and direct therapeutic devices.

Trial Locations (15)

1070

Erasme Hospital - Belgium, Brussels

2400

Bispebjerg Hospital, Denmark, København NV

10032

Columbia University Medical Center, New York

15123

University of Pittsburgh, Pittsburgh

19111

Fox Chase Cancer Center, Philadelphia

44195

Cleveland Clinic Foundation, Cleveland

69437

Hopital Edouard Herriot, Lyon

80045

University of Colorado Hospital, Aurora

94120

California Pacific Medical Center, San Francisco

46202-5253

Indiana University Medical Center, Indianapolis

02215

Beth Israel Deaconess Medical Center, Boston

55905-0001

Mayo Clinic, Rochester

29425-0001

Medical University of South Carolina, Charleston

D-40217

Evangelisches Krankenhaus Dusseldorf, Düsseldorf

00161

Policlinico Agostino Gemelli, Roma

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY